Hepatocerebral Degeneration Overview
Learn About Hepatocerebral Degeneration
Hepatocerebral degeneration is a brain disorder that occurs in people with liver damage.
Chronic acquired (Non-Wilsonian) hepatocerebral degeneration; Hepatic encephalopathy; Portosystemic encephalopathy
This condition may occur in any case of acquired liver failure, including severe hepatitis.
Liver damage can lead to the buildup of ammonia and other toxic materials in the body. This happens when the liver doesn't work properly. It does not break down and eliminate these chemicals. The toxic materials can build up in the brain and damage brain tissue. However, ammonia may not be the cause of hepatocellular degeneration.
Specific areas of the brain, such as the basal ganglia, are more likely to be injured from liver failure. The basal ganglia help control bodily movement. This condition is the "non-Wilsonian" type. This means that the liver damage is not caused by Wilson disease, which leads to copper deposits in the liver. Damage to the basal ganglia can cause symptoms similar to Parkinson disease.
A condition called hepatic encephalopathy can also cause similar symptoms. It is more frequent than hepatocerebral degeneration. It also can occur with hepatocerebral degeneration.
Symptoms may include:
- Difficulty walking
- Impaired intellectual function
- Jaundice
- Muscle spasm (myoclonus)
- Rigidity
- Shaking of arms, head (tremor)
- Twitching
- Uncontrolled body movements (chorea)
- Tremor of the hand when the wrist is extended (also called a flapping tremor or asterixis)
- Unsteady walking (ataxia)
The treatment includes trying medicines that are used for hepatic encephalopathy. This includes antibiotics (such as rifaximin) or a medicine such as lactulose, which lowers the level of ammonia in the blood.
Trying to correct the “shunt” (blood flow changes) from the liver disease may help. This may be done by interventional radiology or surgery.
There is no specific treatment for the neurologic syndrome, because it is caused by irreversible liver damage. A liver transplant may cure the liver disease. However, this operation may help, but not reverse the symptoms of brain damage.
Peter Ferenci is a Hepatologist in Vienna, Austria. Mr. Ferenci is rated as an Elite expert by MediFind in the treatment of Hepatocerebral Degeneration. His top areas of expertise are Hepatocerebral Degeneration, Hepatitis C, Wilson Disease, Hepatitis, and Liver Transplant.
Marina Berenguer practices in Valencia, Spain. Ms. Berenguer is rated as an Elite expert by MediFind in the treatment of Hepatocerebral Degeneration. Her top areas of expertise are Hepatitis C, Hepatocerebral Degeneration, Hepatitis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.
Yale University
Michael Schilsky is a Gastroenterologist and a Hepatologist in New Haven, Connecticut. Dr. Schilsky has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Hepatocerebral Degeneration. His top areas of expertise are Wilson Disease, Hepatocerebral Degeneration, Liver Failure, Liver Transplant, and Endoscopy.
This is a long-term (chronic) condition that may lead to permanent nervous system (neurological) symptoms.
The person may continue to get worse and die without a liver transplant. If a transplant is done early, the neurological syndrome may improve.
Complications include:
- Hepatic coma
- Severe brain damage with a wide range of possible symptoms
Contact your health care provider if you have any symptoms of liver disease.
It is not possible to prevent all forms of liver disease. However, alcohol-related, metabolic-related, and many types of viral hepatitis may be prevented.
To reduce your risk of getting alcohol-related or viral hepatitis:
- Avoid risky behaviors, such as IV drug use or unprotected sex.
- Don't drink, or drink only in moderation.
Summary: Decentralized study to assess patient reported treatment satisfaction comparing their current standard-of-care Wilson's Disease (WD) treatment with a new once-daily Trientine (TETA) 4HCl formulation.
Summary: Longitudinal, observational, non-interventional, standard of care Registry. Data will be collected from the routinely scheduled WD clinic visits at approximately 6-12 month intervals. At enrolment, in addition to data from the clinic visit, retrospective data will be collected from the diagnostic evaluation and any relevant past medical history and a summary of WD medication history.
Published Date: October 30, 2024
Published By: Jenifer K. Lehrer, MD, Gastroenterologist, Philadelphia, PA. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Garcia-Tsao G. Cirrhosis and its sequelae. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 139.
ul Haq I, Liebenow B, Okun MS. Clinical overview of movement disorders. In: Winn HR, ed. Youmans and Winn Neurological Surgery. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 105.

